Full Text:


Ǵм Vol.24_No.2 Suppl. P.S416-423, Dec. 2007

Original Article

T2 ȯ ħ̿ Ұ

The Clinical Relevance of Distinguishing pT2 Gastric Cancer According to the Depth of Invasion and a Difference of Prognosis

輼, ۼ,
б ǰ ܰб
åڣ, 뱸 5 317-1, б ǰ ܰб
Tel: (053) 620-3589, Fax: (053) 624-1213
E-mail: swkim@med.yu.ac.kr

December 30, 2007


PurposeA difference of a pathologic characteristic in proportion to depth of invasion analyzed in T2 gastric cancer and a difference of depth of invasion examined an influence to lymph node metastasis and prognosis.
Materials and MethodsThe clinicopathologic outcomes of 432 patients who underwent curative resection for pT2 stage gastric cancers from 1995 to 1999 were reviewed retrospectively. We are compared on lymphatic metastasis, stage distribution, histologic classification, Bormanns classification, Lauren classification, vessel invasion, lymphatic invasion, neural invasion and 5-year survival rate of pT2 groups(mp vs. ss).
ResultspT2b(ss) group compare to pT2a(mp) in Lauren classification, ratio of diffused type was higher(p<0.05) and in Bormann classification, infiltration type was higher (p<0.01). Vessel and lymphatic invasion, neural invasion showed significant difference between pT2a(mp) and pT2b(ss) (p<0.01). Difference noted between pT2a(mp) and pT2b(ss) group in a lymph node metastatic rate, degree of a metastasis and stage distribution (p<0.01). On stratifying patients according to depth of invasion, 5-year suvival rate for those with pT2a(mp) group was significantly greater than those with pT2b(ss) group(82.4% vs. 47.4%, respectively: P<0.01). In this study, appeared with the significant prognostic factor in 5-year suvival rate which multivariate analysis, depth of invasion(P<0.05) and lymph node metastasis (P<0.01) that enforced the total gastric cancer patient who had T2 gastric cancer with the object noted, but for patients with accurately staged pN0 group, suvival characteristics were similar for pT2a (mp) and pT2b(ss) gastric cancer (P=0.97).
ConclusionThe subclassification of pT2 gastric cancer into pT2a(mp) and pT2b(ss) is necessary to demonstrate their different prognosis.

Key Words: pT2a(mp), pT2b(ss), N stage, Gastric cancer


1. Korea national statistical office. Annual report of the cause of death statistics. 2004.

2. Maruyama K, Sasako M, Kinoshita T, Sano T, Katai H, Hada M. Should systematic lymph node dissection be recommended for gastric cancer? Eur J Cancer 1998 Sep;34(10): 1480-9.

3. Kim JP, Lee JH, Kim SJ, Yu HJ, Yang HK. Clinicopathologic characteristic and prognostic factors in 10783 patients with gastric cancer. Gastric Cancer 1998;1:125-33.

4. Siewert JR, Bottcher K, Stein HJ, Roder JD. Relevent prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 1998 Oct;228(4):449-61.

5. Maehara Y, Anai H, Moriguchi S, Watanabe A, Tsujitani S, Sugimachi K. Gastric carcinoma invading muscularis propria and macroscopic appearance. Eur J Surg Oncol 1992 Apr;18(2): 131-4.

6. Jatzko GR, Lisborg PH, Denk H, Klimpfinger M, Stettner HM. A 10-year experience with Japanese type radical lymph node dissection for gastric cancer outside of Japan. Cancer 1995 Oct 15;76(8):1302-12.

7. Folli S, Morgagni P, Roviello F, De Manzoni G, Marrelli D, Saragoni L, et al. Risk factors for lymph node metastases and their prognostic significance in early gastric cancer (EGC) for the Italian Research Group for Gastric Cancer (IRGGC). Jpn J Clin Oncol 2001 Oct;31(10): 495-9.

8. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, et al. AJCC cancer staging manual. 6th edition. New York:Springer;2002.

9. Sarela AI, Turnbull AD, Coit DG, Klimstra D, Brennan MF, Karpeh MS. Accurate lymph node staging is of greater prognostic importance than subclassification of the T2 category for gastric adenocarcinoma. Ann Surg Oncol 2003 Aug;10(7):783-91.

10. Yokota T, Kunii Y, Teshima S, Yamada Y, Saito T, Kikuchi S, et al. Gastric cancer with invasion limited to the muscularis propria. Int Surg 1999 Jan-Mar;84(1):7-12.

11. Isozaki H, Fujii K, Nomura E, Mabuchi H, Nishiguchi K, Hara H, et al. Prognostic factor of advanced gastric carcinoma without serosal invasion (pT2 gastric carcinoma). Hepatogas- troenterology 1999 Jul-Aug;46(28):2669-72.

12. Okuno K, Shigeoka H, Tanaka A, Hirai N, Matsumura E, Yasutomi M. Clinicopathological evaluation of T2-gastric cancer among age groups. Hepatogastroenterology 2000 Jul-Aug; 47(34):1180-2.

13. Bonekamp JJ, Hermans J, Sasako M, Van De Velde CJH. Extended lymph-node dissection for gastric cancer. N Engl J Med 1999 Mar 25;340(12):908-14.

14. Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, et al. Patient survival after D1 and D2 resections for gastric cancer: long-term result of the MRC randomized surgical trial. Surgical Cooperative Group. Br J Cancer. 1999 Mar;79(9-10):1522-30.